three of these factors -- recombinant human erythropoietin ( r-huepo ) , granulocyte macrophage colony-stimulating factor ( gm-csf ) , and granulocyte colony-stimulating factor ( g-csf ) -- are currently undergoing clinical trials and appear to offer considerable promise for the treatment of a variety of hematopoietic abnormalities .
C0086418
human
C0079459
granulocyte colony-stimulating factor